Printer Friendly, Inc. Commences National Retail Distribution of Cinnergen Diabetes Product; General Nutrition Centers (GNC) to Begin Retail Distribution of Cinnergen(TM).

SCOTTSDALE, Ariz. -- Patricia Gruden, President/CEO of, Inc. (OTCBB:EFSF), announced today that General Nutrition Centers, Inc., a wholly-owned subsidiary of GNC Corporation (, with over 5,000 retail locations throughout the United States and with more than 800 locations in more than 35 foreign markets and an online GNC Store powered through (, placed its initial purchase orders for Cinnergen(TM), an all-natural liquid nutritional supplement designed to regulate blood sugar.

GNC is the world's largest company of its kind devoted exclusively to helping its customers improve their quality of life and Cinnergen fits into the format of this commitment.

"We are elated to receive our initial purchase order from General Nutrition Centers, as they are the largest global specialty retailer of nutritional supplements. We feel confident other large national retailers will also be attracted to the Cinnergen product as its recognition and consumer awareness increases through our continued direct response national radio and television marketing campaigns," commented Mrs. Gruden.

About GNC Corporation

As of December 31, 2005, GNC Corporation, headquartered in Pittsburgh, Pennsylvania, operated 2,650 company-owned stores in the U.S. and Canada and had 1,156 domestic franchised locations, 1,149 Rite Aid "store-within-a-store" locations and 858 international franchised locations. GNC is the largest global specialty retailer of nutritional supplements, including vitamin, mineral and herbal supplements, sports nutrition products, diet and energy products and other wellness products.

About Cinnergen(TM)

Cinnergen(TM) ( is a once-a-day formula made from 15 whole foods that contain no fats, carbohydrates, sugar, or calories. Cinnergen(TM) is specially formulated to promote healthy glucose metabolism and to decrease the symptoms that commonly accompany elevated blood sugar and its effects. Cinnergen(TM) delivers concentrated nutrition to help the body efficiently and effectively metabolize sugar. As a whole food complex, Cinnergen(TM) provides several key ingredients that have been proven clinically through years of research to improve digestion and utilization of sugar, which are generally deficient in a typical American diet.

About, Inc., Inc. is dedicated to improving food and health conditions around the world through its innovative technologies. The company's Knock-Out Technologies, Ltd. subsidiary has developed an environmentally safe sporicidal product formulated entirely of food-grade components that eradicates anthrax and a germicidal product, Big 6 Plus - EPA Reg. No. 82723-1 that kills six major bacteria: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus, Avian Influenza, and Black Mold. The sporicidal product has completed its final efficacy laboratory study requisite for EPA registration. In the study, it eradicated both Clostridium Sporogenes and Bacillus Subtilis with 100% efficacy on both hard and porous surfaces. The company's MedElite, Inc. subsidiary distributes clinically proven products to physicians who then prescribe the products for their patients. It is the exclusive U.S. and worldwide distributor of the Talsyn(TM)-CI/bid Scar Cream that has been clinically proven to facilitate and improve the appearance, redness and strength of scars ( The company is also is a distributor for Cinnergen(TM), a non-prescription liquid whole food nutritional supplement that promotes healthy glucose metabolism (, and most recently became a distributor for Trimmendous(TM), a weight loss formula focusing on the body's 24-hour metabolic processes.

Safe Harbor Forward-Looking Statements

Statements contained in this release that are not strictly historical are "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933 as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements are made based on information available as of the date hereof, and the company assumes no obligation to update such forward-looking statements. Editors and investors are cautioned that such forward-looking statements invoke risk and uncertainties and the company's actual results may differ from these forward-looking statements. Such risks and uncertainties include, but are not limited to, demand for the company's products and services, our ability to continue to develop markets, general economic conditions, our ability to secure additional financing for the company and other factors that may be more fully described in reports to shareholders and periodic filings with the Securities and Exchange Commission.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Mar 7, 2006
Previous Article:Trivial Pursuit(R) Mobile Unveils Top Ten ``Smartest'' Area Codes in U.S.
Next Article:Singer-Songwriter Chantal Chamandy Blends Exotic Heritage of Egyptian Origins with Dramatic Multi-Cultural Influences; ''You Want Me'' Single Debuts...

Related Articles, Inc. Signs Distribution Agreement for Diabetes/Hypoglycemic Product; Cinnergen(TM) to Enter $132 Billion Domestic Diabetes Market. Inc. Announces Expansion of Marketing Program for Clinically Proven Diabetes/Hypoglycemic Product; Cinnergen(TM) to Begin National..., Inc.'s Cinnergen Diabetes Product Available for Sale at Major Internet Retailer,, Inc.'s, Cinnergen Diabetes Product to Be Sold at Regional Retail Chain, Richard's Whole Foods., Inc. Commences Human Clinical Trials on Cinnergen Diabetes Product; Bucks County Clinical Research, Inc to Conduct 50 Patient Study., Inc. Commences Distribution of Cinnergen Diabetes Product to Independent Regional Drug Distributors. Inc. Continues Regional Retail Growth in Northeastern United States; Kinray Inc., with Sales in Excess of $3.5 Billion Annually, to..., Inc. Continues National Roll-Out of Cinnergen(TM) Diabetes Product; The Vitamin Shoppe(R) to Begin National Retail Distribution of..., Inc. Announces Reorders from GNC and The Vitamin Shoppe for Cinnergen Diabetes Product. Inc. Launches CNN Headline News Daytime Edition Advertising Campaign for Cinnergen Diabetes Product Targeting More Than 20 Million...

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters